Annual CAPEX
N/A
December 31, 2023
Summary
- PTIX annual capital expenditures is not available.
Performance
PTIX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- PTIX quarterly capital expenditures is not available.
Performance
PTIX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- PTIX TTM capital expenditures is not available.
Performance
PTIX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
PTIX CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
PTIX CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time |
Protagenic Therapeutics CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2011 | - | $220.00 K(+349.0%) | $911.00 K(+31.3%) |
Jun 2011 | - | $49.00 K(-92.4%) | $694.00 K(+6.1%) |
Mar 2011 | - | $642.00 K(>+9900.0%) | $654.00 K(+1495.1%) |
Dec 2010 | $41.00 K(-94.0%) | $0.00(-100.0%) | $41.00 K(-14.6%) |
Sep 2010 | - | $3000.00(-66.7%) | $48.00 K(-89.5%) |
Jun 2010 | - | $9000.00(-69.0%) | $456.00 K(-8.2%) |
Mar 2010 | - | $29.00 K(+314.3%) | $497.00 K(-27.1%) |
Dec 2009 | $682.00 K(-66.4%) | $7000.00(-98.3%) | $682.00 K(-29.5%) |
Sep 2009 | - | $411.00 K(+722.0%) | $967.00 K(-26.8%) |
Jun 2009 | - | $50.00 K(-76.6%) | $1.32 M(-29.0%) |
Mar 2009 | - | $214.00 K(-26.7%) | $1.86 M(-8.3%) |
Dec 2008 | $2.03 M(+662.8%) | $292.00 K(-61.8%) | $2.03 M(+10.5%) |
Sep 2008 | - | $765.00 K(+29.9%) | $1.84 M(+64.0%) |
Jun 2008 | - | $589.00 K(+53.8%) | $1.12 M(+88.9%) |
Mar 2008 | - | $383.00 K(+283.0%) | $593.00 K(+122.9%) |
Dec 2007 | $266.00 K(+245.5%) | $100.00 K(+108.3%) | $266.00 K(+60.2%) |
Sep 2007 | - | $48.00 K(-22.6%) | $166.00 K(+40.7%) |
Jun 2007 | - | $62.00 K(+10.7%) | $118.00 K(+268.8%) |
Mar 2007 | - | $56.00 K(-333.3%) | $32.00 K(>+9900.0%) |
Dec 2006 | $77.00 K | - | - |
Jul 2006 | - | -$24.00 K(-200.0%) | $0.00(-100.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Apr 2006 | - | $24.00 K(-82.9%) | $24.00 K(-95.3%) |
Apr 2003 | - | $140.00 K(-78.9%) | $513.00 K(-52.0%) |
Jan 2003 | - | $665.00 K(+91.6%) | $1.07 M(-18.2%) |
Oct 2002 | - | $347.00 K(-154.3%) | $1.30 M(-26.8%) |
Jul 2002 | $1.78 M(-8.6%) | -$639.00 K(-191.9%) | $1.78 M(+7.6%) |
Apr 2002 | - | $695.00 K(-22.9%) | $1.66 M(-11.4%) |
Jan 2002 | - | $902.00 K(+9.3%) | $1.87 M(+2.9%) |
Oct 2001 | - | $825.00 K(-207.8%) | $1.82 M(-6.8%) |
Jul 2001 | $1.95 M(-39.6%) | -$765.00 K(-184.3%) | $1.95 M(-66.7%) |
Apr 2001 | - | $908.00 K(+6.9%) | $5.86 M(+35.0%) |
Jan 2001 | - | $849.00 K(-11.4%) | $4.34 M(+3.6%) |
Oct 2000 | - | $958.00 K(-69.5%) | $4.19 M(+29.7%) |
Jul 2000 | $3.23 M(-9.0%) | $3.14 M(-614.8%) | $3.23 M(+38.1%) |
Apr 2000 | - | -$610.00 K(-187.1%) | $2.34 M(-28.0%) |
Jan 2000 | - | $700.00 K(-68.9%) | $3.25 M(-8.5%) |
Jul 1999 | $3.55 M(+5360.0%) | $2.25 M(+649.7%) | $3.55 M(-283.4%) |
Apr 1999 | - | $300.00 K(-70.0%) | -$1.94 M(-4.9%) |
Jan 1999 | - | $1.00 M(-130.9%) | -$2.04 M(-3230.8%) |
Jul 1998 | $65.00 K(-35.0%) | -$3.23 M(-1717.5%) | $65.00 K(-98.0%) |
Apr 1998 | - | $200.00 K(-93.5%) | $3.30 M(+6.5%) |
Jan 1998 | - | $3.10 M | $3.10 M |
Jul 1997 | $100.00 K | - | - |
FAQ
- What is the all time high annual CAPEX for Protagenic Therapeutics?
- What is the all time high quarterly CAPEX for Protagenic Therapeutics?
- What is the all time high TTM CAPEX for Protagenic Therapeutics?
What is the all time high annual CAPEX for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual capital expenditures is $3.55 M
What is the all time high quarterly CAPEX for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly capital expenditures is $3.14 M
What is the all time high TTM CAPEX for Protagenic Therapeutics?
Protagenic Therapeutics all-time high TTM capital expenditures is $5.86 M